C1 Begins New Era of Growth and Innovation to Elevate Connected Human Experiences
Emerges from Financial Restructuring with Deleveraged Balance Sheet and Strengthened Liquidity Which Will Enable Investments to Create and Deliver World-Class Technology... Read more.
AffableBPM names Greg Chavers as new Chief Revenue & Sales Officer to drive innovation in healthcare automation
SEATTLE, June 4, 2024 /PRNewswire/ — AffableBPM, a leader in AI-powered business process automation for healthcare back-office operations and a certified woman-owned... Read more.
Engage Check-In Revolutionizes Student Attendance by Engaging Parents
Innovative Software Solution to Boost Student Attendance through Parental Involvement Windsor, Conn., June 4, 2024 /PRNewswire/ — ReFrame Solutions, a company... Read more.
Halozyme to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
SAN DIEGO, June 4, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Dr. Helen Torley, president... Read more.
Gaming Innovation Group – Mandatory notification of trade
ST JULIANS, Malta, June 4, 2024 /PRNewswire/ — Reference is made to today’s announcement from Gaming Innovation Group Inc. (GiG) regarding a SEK 100... Read more.
Denis Ricard, President and Chief Executive Officer of iA Financial Group, to speak at TD Financial Services & Fintech Summit
QUEBEC CITY, June 4, 2024 /CNW/ – Denis Ricard, President and Chief Executive Officer of iA Financial Group, will participate in a fireside chat as part... Read more.
Modernizing Higher Education: Info-Tech Research Group Identifies Four Exponential IT Priorities to Improving Academic Delivery
Info-Tech Research Group has released a comprehensive guide to adopting an Exponential IT mindset in higher education to address key industry challenges, such as... Read more.
Purple to Participate in Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
LEHI, Utah, June 4, 2024 /PRNewswire/ — Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”) a comfort innovation company known for creating the “World’s... Read more.
Acquisition of Fusion Pharmaceuticals Completed
HAMILTON, ON and BOSTON, June 4, 2024 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing... Read more.
Azenta Announces Collaboration with the Crohn’s & Colitis Foundation to Support its Crohn’s Disease and Ulcerative Colitis Clinical Research
Azenta has been Selected by the Crohn’s & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE... Read more.